希少腎疾患の世界市場レポート 2023年以下を含む1）対象疾患別IgA腎症、ループス腎炎、巣状分節性糸球体硬化症、膜性腎症、C3糸球体症2) 分子のタイプ別：低分子；生物製剤3) 投与経路別：経口；静脈内；皮下Merck & Co：対象：Merck & Co.Inc.、Novartis AG、Sanofi S.A.、AstraZeneca plc、GlaxoSmithKline plc

Rare Kidney Diseases Global Market Report 2023Including: 1) By Target Indication: IgA Nephropathy; Lupus Nephritis; Focal Segmental Glomerular Sclerosis; Membranous Nephropathy; C3 Glomerulopathy2) By Type of Molecule: Small Molecules; Biologics3) By Route of administration: Oral; Intravenous; SubcutaneousCovering: Merck & Co. Inc.; Novartis AG; Sanofi S.A; AstraZeneca plc; GlaxoSmithKline plc

The Business Research Companyの希少腎臓病の世界市場レポート2023年は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。このレポートは力強い成長を遂げて... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Business Research Company　(TBRC) ザ・ビジネスリサーチカンパニー	2023年9月21日	US$5,000 シングルユーザライセンスライセンス・価格情報注文方法はこちら	175	英語

サマリー

The Business Research Companyの希少腎臓病の世界市場レポート2023年は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。

このレポートは力強い成長を遂げている希少腎臓病市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。

購入の理由
- 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真にグローバルな視点を得ることができます。
- 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。
- ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。
- 世界的な高インフレが市場成長に与える影響を測定する。
- 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。
- 最新の市場シェアに基づいて顧客を理解する。
- 主要な競合他社に対する業績のベンチマーク
- 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。
- レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3～5営業日以内にお届けします。
- レポートの全データは、エクセルのダッシュボード形式でも納品されます。

説明
希少腎臓病市場が最も大きく急成長しているのはどこか？経済全体、人口動態、他の類似市場との関連は？今後どのような力が市場を形成していくのか？ビジネスリサーチ社の希少腎疾患市場グローバルレポートは、これらすべての質問とその他多くの質問に回答します。

当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、トレンド、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。

- 市場特性のセクションでは、市場を定義し説明しています。
- 市場規模のセクションでは、市場の歴史的な成長と発展の予測の両方をカバーする市場規模（bドル）を示します。
- 予測は、現在市場に影響を与えている主な要因を考慮した上で行っています。これらには以下が含まれる：
- ロシア・ウクライナ戦争による制裁措置、サプライチェーンの混乱、商品・サービス需要の変化による影響、東欧地域の様々なマクロ経済要因やパラメータへの影響、その後の世界市場への影響。
- 多くの国々におけるインフレ率の上昇とそれに伴う金利の急上昇の影響。
- COVID-19がサプライチェーンと消費パターンに与える影響の継続と減少。
- 市場セグメンテーションでは、市場をサブマーケットに分類している。
- 地域別および国別の内訳では、各地域の市場分析と地域別の市場規模を示し、それらの過去および予測成長率を比較している。全地域、主要先進国、主要新興国のCOVID-19の成長軌跡を網羅しています。
- 競合環境の章では、市場の競合性、市場シェア、主要企業について解説しています。近年市場を形成してきた主要な金融取引についても明らかにしている。
- トレンドと戦略の章では、危機から脱した市場の形状を分析し、市場が回復する中で企業がどのように成長できるかを示唆している。

調査範囲

対象市場：1）適応症別IgA腎症；ループス腎炎；巣状分節性糸球体硬化症；膜性腎症；C3糸球体症；その他の適応症
2) 分子の種類別低分子；生物製剤
3) 投与経路別経口；静脈内；皮下；その他の投与経路

言及された企業Merck & Co.Inc、Novartis AG、Sanofi S.A、AstraZeneca plc、GlaxoSmithKline plc

国オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列：過去5年間および過去10年間の予測。

データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、

データ区分：国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照：本レポート中のデータおよび分析は、エンドノートを使用しています。

納品形式PDF、Word、Excel データダッシュボード。

ページTOPに戻る

1. Executive Summary
2. Rare Kidney Diseases Market Characteristics
3. Rare Kidney Diseases Market Trends And Strategies
4. Rare Kidney Diseases Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Rare Kidney Diseases Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Rare Kidney Diseases Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Rare Kidney Diseases Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Rare Kidney Diseases Market Segmentation
6.1. Global Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
IgA Nephropathy
Lupus Nephritis
Focal Segmental Glomerular Sclerosis
Membranous Nephropathy
C3 Glomerulopathy
Other Target Indications
6.2. Global Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Small Molecules
Biologics
6.3. Global Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Oral
Intravenous
Subcutaneous
Other Routes of Administration
7. Rare Kidney Diseases Market Regional And Country Analysis
7.1. Global Rare Kidney Diseases Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Rare Kidney Diseases Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Rare Kidney Diseases Market
8.1. Asia-Pacific Rare Kidney Diseases Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Rare Kidney Diseases Market
9.1. China Rare Kidney Diseases Market Overview
9.2. China Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Rare Kidney Diseases Market
10.1. India Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Rare Kidney Diseases Market
11.1. Japan Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Rare Kidney Diseases Market
12.1. Australia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Rare Kidney Diseases Market
13.1. Indonesia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Rare Kidney Diseases Market
14.1. South Korea Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Rare Kidney Diseases Market
15.1. Western Europe Rare Kidney Diseases Market Overview
15.2. Western Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Rare Kidney Diseases Market
16.1. UK Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Rare Kidney Diseases Market
17.1. Germany Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Rare Kidney Diseases Market
18.1. France Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Rare Kidney Diseases Market
19.1. Italy Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Rare Kidney Diseases Market
20.1. Spain Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Rare Kidney Diseases Market
21.1. Eastern Europe Rare Kidney Diseases Market Overview
21.2. Eastern Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Rare Kidney Diseases Market
22.1. Russia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Rare Kidney Diseases Market
23.1. North America Rare Kidney Diseases Market Overview
23.2. North America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Rare Kidney Diseases Market
24.1. USA Rare Kidney Diseases Market Overview
24.2. USA Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Rare Kidney Diseases Market
25.1. Canada Rare Kidney Diseases Market Overview
25.2. Canada Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Rare Kidney Diseases Market
26.1. South America Rare Kidney Diseases Market Overview
26.2. South America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Rare Kidney Diseases Market
27.1. Brazil Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Rare Kidney Diseases Market
28.1. Middle East Rare Kidney Diseases Market Overview
28.2. Middle East Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Rare Kidney Diseases Market
29.1. Africa Rare Kidney Diseases Market Overview
29.2. Africa Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Rare Kidney Diseases Market Competitive Landscape And Company Profiles
30.1. Rare Kidney Diseases Market Competitive Landscape
30.2. Rare Kidney Diseases Market Company Profiles
30.2.1. Merck & Co. Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Novartis AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Sanofi S.A
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. AstraZeneca plc
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. GlaxoSmithKline plc
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Rare Kidney Diseases Market Other Major And Innovative Companies
31.1. Otsuka Pharmaceutical Co Ltd.
31.2. Alexion Pharmaceuticals Inc.
31.3. Horizon Therapeutics plc.
31.4. Recordati S.p.A.
31.5. Proteostasis Therapeutics
31.6. Amicus Therapeutics Inc.
31.7. Akebia Therapeutics Inc.
31.8. Travere Therapeutics
31.9. FibroGen Inc.
31.10. Aurinia Pharmaceuticals Inc.
31.11. Calliditas Therapeutics AB
31.12. Apellis Pharmaceuticals Inc.
31.13. Protalix Biotherapeutics Inc.
31.14. ChemoCentryx Inc.
31.15. Omeros Corporation
32. Global Rare Kidney Diseases Market Competitive Benchmarking
33. Global Rare Kidney Diseases Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Rare Kidney Diseases Market
35. Rare Kidney Diseases Market Future Outlook and Potential Analysis
35.1 Rare Kidney Diseases Market In 2027 - Countries Offering Most New Opportunities
35.2 Rare Kidney Diseases Market In 2027 - Segments Offering Most New Opportunities
35.3 Rare Kidney Diseases Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

ページTOPに戻る

Table of Contents

Summary

Rare Kidney Diseases Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rare kidney diseases market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for rare kidney diseases? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rare kidney diseases market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:
• The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
• The impact of higher inflation in many countries and the resulting spike in interest rates.
• The continued but declining impact of COVID-19 on supply chains and consumption patterns.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Target Indication: IgA Nephropathy; Lupus Nephritis; Focal Segmental Glomerular Sclerosis; Membranous Nephropathy; C3 Glomerulopathy; Other Target Indications
2) By Type of Molecule: Small Molecules; Biologics
3) By Route of administration: Oral; Intravenous; Subcutaneous; Other Routes of Administration

Companies Mentioned: Merck & Co. Inc.; Novartis AG; Sanofi S.A; AstraZeneca plc; GlaxoSmithKline plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

The Business Research Company　(TBRC)社の医薬分野での最新刊レポート

本レポートと同じKEY WORD（administration）の最新刊レポート

よくあるご質問

The Business Research Company　(TBRC)社はどのような調査会社ですか?

The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医薬）の最新刊レポート

The Business Research Company (TBRC)社の医薬分野での最新刊レポート

本レポートと同じKEY WORD（administration）の最新刊レポート

よくあるご質問

The Business Research Company (TBRC)社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?

The Business Research Company　(TBRC)社の医薬分野での最新刊レポート

The Business Research Company　(TBRC)社はどのような調査会社ですか?